Secondaries announced 7.30.2015
IPOBoutique.Com rates secondary offerings to hit the tape with a ‘BUY’, ‘NEUTRAL’ or ‘AVOID’ rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary’s he’s issued with a ‘BUY’ rating. Company: AMAG Pharmaceuticals Symbol: AMAG Price: Last trade $64.95 Trade Date: 7/31 Shares: 3 million Underwriter(s) Jefferies, Barclays Capital Rating=Subscription Needed Company:[…]